Ackman's $5.3 Billion Allergan Bet Examined Before Ouster Vote

William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, center, arrives at the federal court in Santa Ana, California, U.S., on Tuesday, Oct. 28, 2014. Ackmans accumulation of $5.3 billion of Allergan Inc. stock is being scrutinized by a judge who must decide whether the hedge fund manager can vote his 10 percent stake to help seal a hostile takeover bid by Valeant Pharmaceuticals International Inc. Photographer: Jonathan Alcorn/Bloomberg via Getty Images
William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, center, arrives at the federal court in Santa Ana, California, U.S., on Tuesday, Oct. 28, 2014. Ackmans accumulation of $5.3 billion of Allergan Inc. stock is being scrutinized by a judge who must decide whether the hedge fund manager can vote his 10 percent stake to help seal a hostile takeover bid by Valeant Pharmaceuticals International Inc. Photographer: Jonathan Alcorn/Bloomberg via Getty Images
Ackman's $5.3 Billion Allergan Bet Examined Before Ouster Vote
PURCHASE A LICENSE
How can I use this image?
kr. 3.000,00
DKK

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
458011232
Collection:
Bloomberg
Date created:
October 28, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ALLERGAN ACKMAN
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 3 MB